JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

342 * Tue, 7/31/2012, 10:30 AM - 12:20 PM CC-Room 28A
Planning and Analysis of Phase I/II Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Grace Liu, Johnson & Johnson
10:35 AM A Time-to-Event Generalized Continual Reassessment Method for Two-Agent Phase I Trials Nan Jia, University of Michigan ; Thomas M Braun, University of Michigan
10:50 AM Posterior Probability of Adverse Events (AE) Categories for Phase I Studies — Kyounghwa Bae, Alcon Laboratories ; John W. Seaman III, PhD, Alcon Laboratories ; Mark VonTress, Alcon Laboratories
11:05 AM Optimal Dose finding for Phase I Cancer Clinical Trials Shanhong Guan, Sanofi
11:20 AM Continual Reassessment Method: A Unified Approach Keying Ye, The University of Texas at San Antonio ; Xiaobin Yang, Analytic Focus, LLC ; Ying Ji, The University of Texas at San Antonio
11:35 AM Flexible Link Continual Reassessment Methods for Trivariate Binary Outcome Phase I/II Trials — Wei Zhong, University of Minnesota ; Bradley P Carlin, University of Minnesota ; Joseph S Koopmeiners, University of Minnesota
11:50 AM Power Calculations Conditioned on a Given Effect Size: Can We Do Better? Peter Hu, Bristol-Myers Squibb ; Ih Chang, Bristol-Myers Squibb
12:05 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.